Evaluation of the effect of an extract of Mangifera indica L. (Vimang®) in patient with Ischemic stroke.

Center of Pharmaceutical Chemistry0 个研究点目标入组 120 人开始时间: 2009年3月13日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

研究类型: Interventional
分配方式: Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

•1. Patient of any sex and race.
•2. Patient older than 41 years.
•3. Patient with ischemic stroke of any localization, with less than 12 hours of evolution of the stroke.
•4. Patient that Computer Axial Tomography by Perfusion is carried out before the 12 hours of initiate the stroke.
•5. Participation consent in the study.

•1.Coma ( Glasgow scale smaller than 8).
•2. Hemorrhage cerebrum-vascular illness or skull trauma in the last three months.
•3.Patient with symptoms or neurological signs that they return to the normality before the beginning of the treatment.
•4. Suspicions of vascular inflammatory illnesses as cause of the current ischemic stroke (lupus and other illnesses of the colagen).
•5. Hypersensibility to the aspirin or iodine.
•6. Pregnancy or nursing
•7. Patient that receive treatment with another antioxidants, some anticoagulant or neuroprotector drugs.

发起方

Center of Pharmaceutical Chemistry